Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


PointBreak and AVAPERL Studies in NSCLC

Maintenance Therapy Clinical Trials for NSCLC

Role of Maintenance Therapy in NSCLC

PD-1/PD-L1 Inhibitors Across NSCLC Treatment Settings

Multiple PD-1/PD-L1 Agents in Lung Cancer

Nivolumab in Non-Small Cell Lung Cancer

PD-1 Inhibition in Lung Cancer

Efficacy of Next-Generation ALK Inhibitors

Utilizing Next-Generation ALK Inhibitors in NSCLC

Next-Generation ALK Inhibitors in NSCLC

Frontline ALK, EGFR Inhibition in NSCLC

Afatinib Plus Cetuximab in Resistant NSCLC

AZD9291 and Rociletinib in T790M-Mutant NSCLC

Next-Generation EGFR Inhibitors in NSCLC

Subgroup Analyses for Nab-Paclitaxel in NSCLC

Maintenance Nab-Paclitaxel in Squamous NSCLC

Nab-Paclitaxel in Non-Small Cell Lung Cancer

Introduction: Exploration of Nab-Paclitaxel in NSCLC

The treatment landscape for patients with non-small cell lung cancer (NSCLC) is poised to undergo dramatic changes, as novel immunotherapies, second-generation targeted therapies, and new maintenance strategies continue to show promise in clinical trials.

Novel Therapies, Strategies in Development for NSCLC

The PD-1 inhibitor nivolumab and the second-generation ALK inhibitor alectinib have each gained their first approvals as treatments for patients in Japan.

Nivolumab, Alectinib Gain Approvals in Japan

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Lung Cancer

Lung Cancer | Specialty